Cite
HARVARD Citation
Shirai, Y. et al. (2022). Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis. Journal of scleroderma and related disorders. 7 (1), pp. 57-61. [Online].